Cargando…

Artificial intelligence and machine learning in precision and genomic medicine

The advancement of precision medicine in medical care has led behind the conventional symptom-driven treatment process by allowing early risk prediction of disease through improved diagnostics and customization of more effective treatments. It is necessary to scrutinize overall patient data alongsid...

Descripción completa

Detalles Bibliográficos
Autor principal: Quazi, Sameer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198206/
https://www.ncbi.nlm.nih.gov/pubmed/35704152
http://dx.doi.org/10.1007/s12032-022-01711-1
_version_ 1784727559947157504
author Quazi, Sameer
author_facet Quazi, Sameer
author_sort Quazi, Sameer
collection PubMed
description The advancement of precision medicine in medical care has led behind the conventional symptom-driven treatment process by allowing early risk prediction of disease through improved diagnostics and customization of more effective treatments. It is necessary to scrutinize overall patient data alongside broad factors to observe and differentiate between ill and relatively healthy people to take the most appropriate path toward precision medicine, resulting in an improved vision of biological indicators that can signal health changes. Precision and genomic medicine combined with artificial intelligence have the potential to improve patient healthcare. Patients with less common therapeutic responses or unique healthcare demands are using genomic medicine technologies. AI provides insights through advanced computation and inference, enabling the system to reason and learn while enhancing physician decision making. Many cell characteristics, including gene up-regulation, proteins binding to nucleic acids, and splicing, can be measured at high throughput and used as training objectives for predictive models. Researchers can create a new era of effective genomic medicine with the improved availability of a broad range of datasets and modern computer techniques such as machine learning. This review article has elucidated the contributions of ML algorithms in precision and genome medicine.
format Online
Article
Text
id pubmed-9198206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91982062022-06-17 Artificial intelligence and machine learning in precision and genomic medicine Quazi, Sameer Med Oncol Review Article The advancement of precision medicine in medical care has led behind the conventional symptom-driven treatment process by allowing early risk prediction of disease through improved diagnostics and customization of more effective treatments. It is necessary to scrutinize overall patient data alongside broad factors to observe and differentiate between ill and relatively healthy people to take the most appropriate path toward precision medicine, resulting in an improved vision of biological indicators that can signal health changes. Precision and genomic medicine combined with artificial intelligence have the potential to improve patient healthcare. Patients with less common therapeutic responses or unique healthcare demands are using genomic medicine technologies. AI provides insights through advanced computation and inference, enabling the system to reason and learn while enhancing physician decision making. Many cell characteristics, including gene up-regulation, proteins binding to nucleic acids, and splicing, can be measured at high throughput and used as training objectives for predictive models. Researchers can create a new era of effective genomic medicine with the improved availability of a broad range of datasets and modern computer techniques such as machine learning. This review article has elucidated the contributions of ML algorithms in precision and genome medicine. Springer US 2022-06-15 2022 /pmc/articles/PMC9198206/ /pubmed/35704152 http://dx.doi.org/10.1007/s12032-022-01711-1 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Quazi, Sameer
Artificial intelligence and machine learning in precision and genomic medicine
title Artificial intelligence and machine learning in precision and genomic medicine
title_full Artificial intelligence and machine learning in precision and genomic medicine
title_fullStr Artificial intelligence and machine learning in precision and genomic medicine
title_full_unstemmed Artificial intelligence and machine learning in precision and genomic medicine
title_short Artificial intelligence and machine learning in precision and genomic medicine
title_sort artificial intelligence and machine learning in precision and genomic medicine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198206/
https://www.ncbi.nlm.nih.gov/pubmed/35704152
http://dx.doi.org/10.1007/s12032-022-01711-1
work_keys_str_mv AT quazisameer artificialintelligenceandmachinelearninginprecisionandgenomicmedicine